Page last updated: 2024-11-02

pentamidine and Cancer of Endometrium

pentamidine has been researched along with Cancer of Endometrium in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research Excerpts

ExcerptRelevanceReference
"Pentamidine has been reported to have many pharmacological effects including anti- protozoal, anti-inflammatory, and anti-tumor activities."1.72Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway. ( Gao, Y; Hu, X; Lin, L; Liu, C; Ouyang, J, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lin, L3
Gao, Y3
Hu, X3
Ouyang, J3
Liu, C3

Other Studies

1 other study available for pentamidine and Cancer of Endometrium

ArticleYear
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022